29th Nov 2011 11:43
TAU CAPITAL PLC
("Tau" or "the Company") APPROVAL FOR CONVERSION OF EQUITY
Tau announces today that it has been granted approval by the Anti-Monopoly Commission of the Republic of Kazakhstan for conversion into equity of the remaining 16.35% interest in Stopharm LLP, the largest pharmaceutical distributor in Kazakhstan by volume. Post-conversion, which Tau anticipates will take place over the next two weeks, Tau will directly hold a 40.35% equity interest in Stopharm LLP.
Further information, please contact:
IOMA Fund & Investment Management Ltd Cynthia Edwards
| Tel: +44 (0) 1624 681250 |
Numis Securities Limited Nominated Adviser: Nick Westlake/Hugh Jonathan Corporate Broking: Alex Ham | Tel: +44 (0) 20 7260 1000
|
Related Shares:
TAU.L